Cohort studyindependent cross-checkabstract only checked★ key study I-CHM-03 in-depth review

Patients who used only alternative medicine for curable cancer died more often

Use of Alternative Medicine for Cancer and Its Impact on Survival.

Overview

Johnson SB et al.. J Natl Cancer Inst 2018 · PMID 28922780 · DOI 10.1093/jnci/djx145

Risk of death was 2.5 times higher overall and 5.7 times higher for breast cancer.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Compare AM-only vs conventional treatment.

How was the study done?

Matched registry cohort.

How many people, animals or samples were studied?

840 matched patients.

What was actually found?

HR 2.50 for death.

How large was the observed effect?

HR 5.68 breast cancer.

What do the results mean in everyday life?

Replacing cancer treatment with alternatives is dangerous.

What are the study's limitations?

Observational.

What does it say about Elawady's specific claim?

Contradicts refusing therapy.

Do the results apply to Germany and Europe?

Moderate.

What can explicitly not be concluded from this study?

Effects of complementary approaches used alongside treatment.

Scientific in-depth review

1. Full reference

Authors
Johnson SB et al.
Journal
J Natl Cancer Inst
Year
2018
Identifier
PMID 28922780 DOI 10.1093/jnci/djx145
Verification
verified – PubMed esummary + efetch 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

not stated in abstract

2. Research question

Survival of patients choosing alternative medicine as sole treatment vs conventional treatment.

3. Study design and population

Study design
Cohort study – Retrospective matched cohort (National Cancer Database)
Population

Nonmetastatic breast, prostate, lung or colorectal cancer

Country

USA

Period

not stated in abstract

Sample size

281 AM patients; matched 280 AM vs 560 CCT

Inclusion and exclusion criteria

AM as sole anticancer treatment without CCT

4. Methods and endpoints

Exposure / intervention

Alternative medicine only

Comparator

Conventional cancer treatment

Endpoints

Overall survival

Statistical methods

2:1 matching; Cox regression

5. Actual results

Results

AM associated with greater risk of death: overall HR 2.50 (95% CI 1.88-3.27); breast HR 5.68 (3.22-10.04); lung 2.17 (1.42-3.32); colorectal 4.57 (1.66-12.61).

Absolute risks

not reported in abstract

Authors' conclusion

Although rare, AM use for curable cancer without conventional treatment is associated with greater risk of death.

6. Strengths

  • National registry
  • Matching on key factors

7. Weaknesses

  • Small AM group
  • Observational; residual confounding
  • AM category heterogeneous

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Confounding and misclassification possible; effect large and consistent.

9. Assessment of the statistical interpretation

Large hazard ratios across cancer types; not a trial, but randomisation would be unethical.

10. Relevance to the specific claim

Direct evidence on survival when conventional treatment is replaced by non-medical alternatives such as diet-only approaches.

11. Independent contrary findings

12. Transferability to Germany and Europe

Moderate (US registry).

13. Overall methodological judgement

Key safety evidence against replacing cancer treatment.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitypartly replicated
Consistency with the overall evidenceconsistent
Regional transferabilitymoderate
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Data on specific diet-only approaches.

15. Linked fact checks